Optical Cable Corporation OCC

Optical Cable Corporation (Nasdaq GM: OCC) ("OCC®" or the "Company") today announced financial results for its third quarter of fiscal year 2026 ended July 31, 2026.

Optical Cable Corporation (Nasdaq GM: OCC) ("OCC®") today announced that it will release its third quarter of fiscal year 2026 results on Wednesday, September 9, 2026. The third quarter results are for the three-month and nine-month periods ended July 31, 2026. The Company will also host a conference call on Wednesday, September 9, 2026, at 11:00 a.m. Eastern Time.

The second-largest U.S. bank provided an update to investors about the consent order issued by the OCC in 2024, saying a resolution may include monetary penalties.

Orthocell Ltd (ASX:OCC, OTC:ORHHF) has posted record quarterly and full-year revenue, with accelerating adoption of its Remplir™ nerve repair device in Australia and the United States strengthening the regenerative medicine company’s commercial growth outlook. Revenue reached A$3.8 million in...

The S&P/ASX Small Ordinaries Index finished Friday at 3,392.70 points, gaining 23.50 points, or 0.70%, for the session. Despite the positive finish, the index remained 48.80 points, or 1.42%, lower over the past five trading days. Several ASX-listed small caps delivered operational...

Sony Bank received conditional approval from the OCC to launch a national trust bank subsidiary called Connectia for making its own dollar-backed stablecoins.

Orthocell Ltd (ASX:OCC, OTC:ORHHF) has expanded the humanitarian rollout of its nerve repair device, Remplir™, in Ukraine, following growing use of the product for severe peripheral nerve injuries caused by the ongoing conflict. The regenerative medicine company said additional devices were...

Optical Cable Corporation (Nasdaq GM: OCC) (the "Company" or "OCC®") today announced that it was selected to be included in the Russell Microcap® Index, as part of the 2026 Russell Microcap® Index's semi-annual reconstitution. The Company's addition to the Russell Microcap® Index was effective after market close on Friday, June 26, 2026.

Perth-based regenerative medicine company, Orthocell Ltd (Orthocell), has extended the global reach of its FDA-cleared collagen medical device Remplir™ to Ukraine as part of a coordinated philanthropy effort to provide medical aid to victims of war.